
Cassel Salpeter & Co.’s Q3 healthcare update points to disrupted NIH grant processing, FDA attrition, and tariffs as pressures on drug development and early-stage financing.
VIDA Diagnostics, Inc. has announced the introduction of its AI-powered, cloud-based, VIDA Intelligence Portal (VIP). The portal aims to automate time sensitive tasks such as subject anonymization and quality control workflow processes.






